ATE410158T1 - Fulvinsäure und deren verwendung in der behandlung von viralen infektionen - Google Patents
Fulvinsäure und deren verwendung in der behandlung von viralen infektionenInfo
- Publication number
- ATE410158T1 ATE410158T1 AT06012243T AT06012243T ATE410158T1 AT E410158 T1 ATE410158 T1 AT E410158T1 AT 06012243 T AT06012243 T AT 06012243T AT 06012243 T AT06012243 T AT 06012243T AT E410158 T1 ATE410158 T1 AT E410158T1
- Authority
- AT
- Austria
- Prior art keywords
- viral infections
- fulvic acid
- treatment
- condition
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA989190 | 1998-10-08 | ||
ZA992848 | 1999-04-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE410158T1 true ATE410158T1 (de) | 2008-10-15 |
Family
ID=27144980
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99970022T ATE336997T1 (de) | 1998-10-08 | 1999-10-08 | Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen |
AT06012245T ATE410160T1 (de) | 1998-10-08 | 1999-10-08 | Fulvinsäure und deren verwendung in der behandlung von entzündungen |
AT06012244T ATE410159T1 (de) | 1998-10-08 | 1999-10-08 | Fulvinsäure und deren verwendung in der behandlung von candida infektionen |
AT06012243T ATE410158T1 (de) | 1998-10-08 | 1999-10-08 | Fulvinsäure und deren verwendung in der behandlung von viralen infektionen |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99970022T ATE336997T1 (de) | 1998-10-08 | 1999-10-08 | Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen |
AT06012245T ATE410160T1 (de) | 1998-10-08 | 1999-10-08 | Fulvinsäure und deren verwendung in der behandlung von entzündungen |
AT06012244T ATE410159T1 (de) | 1998-10-08 | 1999-10-08 | Fulvinsäure und deren verwendung in der behandlung von candida infektionen |
Country Status (7)
Country | Link |
---|---|
US (1) | US6569900B1 (de) |
EP (4) | EP1700599B1 (de) |
JP (1) | JP4700808B2 (de) |
AT (4) | ATE336997T1 (de) |
AU (1) | AU766198B2 (de) |
DE (4) | DE69939722D1 (de) |
WO (1) | WO2000019999A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2570565C (en) * | 2004-06-23 | 2012-10-23 | Bioz Agri Products Inc. | Method for extracting fulvic acid molecules |
ZA200705844B (en) * | 2004-12-15 | 2008-09-25 | Van Der Westhuzen Corne Floris | Detoxifying and immunity-booster composition |
JP2006232785A (ja) * | 2005-02-28 | 2006-09-07 | Univ Of Tsukuba | フルボ酸を用いるi型アレルギー抑制剤及びi型アレルギーの発症抑制方法。 |
US20080160111A1 (en) * | 2005-02-28 | 2008-07-03 | Hiroko Isoda | Type I Allergy Inhibitor and Methods of Inhibiting the Onset of Type I Allergy Using Fulvic Acid |
US20070212434A1 (en) * | 2006-03-07 | 2007-09-13 | Day Kenneth S | Compositions and methods for human use containing fulvic acid |
US8114910B2 (en) | 2006-05-02 | 2012-02-14 | Pfeinsmith S.A. (Pty) Ltd. | Acidic composition |
US8445452B2 (en) | 2008-06-05 | 2013-05-21 | Pfeinsmith Ltd. | Fulvic acid and antibiotic combination |
DE102008058552A1 (de) | 2008-11-21 | 2010-05-27 | Mankau, Dieter, Prof. Dr. | Federrahmen und Federkörper zur Abstützung z. B. einer Matratze |
GB0900786D0 (en) * | 2009-01-19 | 2009-03-04 | Natracine Uk Ltd | Therapeutic compositions |
GB0914966D0 (en) | 2009-08-27 | 2009-09-30 | Natracine Uk Ltd | Fulvic acid compositions and their use |
WO2013023062A1 (en) * | 2011-08-09 | 2013-02-14 | Wilford Lynn C | Antimicrobial agents and methods for use thereof in the abatement of food borne pathogenic organisms |
IN2014DN07194A (de) * | 2012-03-07 | 2015-04-24 | Natracine Uk Ltd | |
CN105246879A (zh) | 2013-05-28 | 2016-01-13 | 英派尔科技开发有限公司 | 腐植酸衍生物以及制备的方法和用途 |
US9932319B2 (en) | 2013-05-28 | 2018-04-03 | Empire Technology Development Llc | Antioxidant humic acid derivatives and methods of preparation and use |
WO2014209369A1 (en) | 2013-06-28 | 2014-12-31 | Empire Technology Development Llc | Edible plasticizers for food and food packaging films |
WO2017102565A1 (en) * | 2015-12-15 | 2017-06-22 | Rita Dobmeyer | Pharmaceutical composition comprising a fulvic acid and at least one boron-containing compound |
US9820953B2 (en) * | 2016-02-26 | 2017-11-21 | Omni Bioceutical Innovations, Inc. | Compositions of bioactive fulvate fractions and uses thereof |
JP6120342B1 (ja) * | 2016-03-08 | 2017-04-26 | 株式会社スタイルアンドバリュージャパン | 美容組成物 |
US20220160649A1 (en) * | 2019-03-20 | 2022-05-26 | Rita DOBMEYER | Pharmaceutical composition |
EP3799854A1 (de) | 2019-10-01 | 2021-04-07 | Stefan Johannes Fellner | Extrakt von organischen humifizierten materialien |
KR102258006B1 (ko) * | 2020-12-22 | 2021-05-28 | 허교 | 풀빅산을 유효성분으로 포함하는 항바이러스 조성물 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB244215A (en) | 1924-10-09 | 1925-12-17 | Richard William Bailey | Improvements in or relating to gas or oil power plant |
DE2850685A1 (de) * | 1978-11-22 | 1980-06-04 | Kneer Franz X | Verfahren zur herstellung eines kolloiden schlammbades und schlammartiger pasten fuer die heilbehandlung |
US5204368A (en) * | 1990-05-25 | 1993-04-20 | National Energy Council | Bacteriostatic and bacteriocidal method using fulvic acid derivatives |
JPH0466508A (ja) * | 1990-07-03 | 1992-03-02 | Suntory Ltd | 抗菌剤 |
JPH0687752A (ja) * | 1992-09-04 | 1994-03-29 | Kyowa Kagaku Kogyo Kk | 抗菌水及びこの抗菌水の製造方法 |
CN1097990A (zh) * | 1994-01-29 | 1995-02-01 | 康宏盛 | 一种治疗股癣的药物 |
JPH1017483A (ja) * | 1996-06-26 | 1998-01-20 | Keinzu Corp:Kk | 皮膚疾患予防及び治療剤 |
TR199802702T2 (xx) * | 1996-06-27 | 1999-05-21 | Organoflo (Proprietary) Limited | Bir s�v� verim artt�rma maddesinin yap�lmas� i�in bir y�ntem. |
JPH119674A (ja) * | 1997-06-25 | 1999-01-19 | M S K Planning:Kk | フミン酸を有効成分とする液体消臭剤と、その製造方法及びフミン酸を有効成分とした飲料用消臭剤と、その製造方法 |
CN1103339C (zh) * | 1998-08-25 | 2003-03-19 | 祝亚勤 | 药用级泥炭黄腐植酸钠的制备方法 |
-
1999
- 1999-10-08 DE DE69939722T patent/DE69939722D1/de not_active Expired - Lifetime
- 1999-10-08 DE DE69939721T patent/DE69939721D1/de not_active Expired - Lifetime
- 1999-10-08 AT AT99970022T patent/ATE336997T1/de not_active IP Right Cessation
- 1999-10-08 EP EP06012244A patent/EP1700599B1/de not_active Expired - Lifetime
- 1999-10-08 WO PCT/IB1999/001649 patent/WO2000019999A1/en active IP Right Grant
- 1999-10-08 AU AU59923/99A patent/AU766198B2/en not_active Ceased
- 1999-10-08 AT AT06012245T patent/ATE410160T1/de not_active IP Right Cessation
- 1999-10-08 US US09/807,004 patent/US6569900B1/en not_active Expired - Lifetime
- 1999-10-08 EP EP99970022A patent/EP1126837B1/de not_active Expired - Lifetime
- 1999-10-08 AT AT06012244T patent/ATE410159T1/de not_active IP Right Cessation
- 1999-10-08 AT AT06012243T patent/ATE410158T1/de not_active IP Right Cessation
- 1999-10-08 EP EP06012245A patent/EP1700600B1/de not_active Expired - Lifetime
- 1999-10-08 EP EP06012243A patent/EP1698333B1/de not_active Expired - Lifetime
- 1999-10-08 JP JP2000573359A patent/JP4700808B2/ja not_active Expired - Fee Related
- 1999-10-08 DE DE69932939T patent/DE69932939T2/de not_active Expired - Lifetime
- 1999-10-08 DE DE69939720T patent/DE69939720D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2002526407A (ja) | 2002-08-20 |
EP1698333B1 (de) | 2008-10-08 |
EP1126837B1 (de) | 2006-08-23 |
EP1700600B1 (de) | 2008-10-08 |
AU766198B2 (en) | 2003-10-09 |
DE69932939T2 (de) | 2006-12-07 |
EP1126837A1 (de) | 2001-08-29 |
EP1700600A1 (de) | 2006-09-13 |
JP4700808B2 (ja) | 2011-06-15 |
DE69939720D1 (de) | 2008-11-20 |
DE69939721D1 (de) | 2008-11-20 |
EP1700599B1 (de) | 2008-10-08 |
EP1700599A1 (de) | 2006-09-13 |
WO2000019999A1 (en) | 2000-04-13 |
AU5992399A (en) | 2000-04-26 |
EP1698333A1 (de) | 2006-09-06 |
ATE410160T1 (de) | 2008-10-15 |
US6569900B1 (en) | 2003-05-27 |
DE69939722D1 (de) | 2008-11-20 |
ATE410159T1 (de) | 2008-10-15 |
DE69932939D1 (de) | 2006-10-05 |
ATE336997T1 (de) | 2006-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69939722D1 (de) | Fulvinsäure und deren Verwendung in der Behandlung von Entzündungen | |
ATE119520T1 (de) | Derivate von hydroxaminsäure und von n- hydroxyharnstoff sowie ihre verwendung. | |
ATE160561T1 (de) | L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen | |
DE69103773D1 (de) | Derivate von hydroxaminsäure die lipoxygenase hemmen. | |
ATE185803T1 (de) | N-hydroxy-harnstoff-derivate als entzündunghemmende mittel | |
ATE271896T1 (de) | Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis | |
BR9608721A (pt) | Composição farmacêutica, e, processo para tratar inflamação | |
ATE193537T1 (de) | Phosphorylierte derivate von verbindungen mit antiinflammatorischen oder analgetischer wirkung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |